{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:06:00Z","timestamp":1779318360471,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johannes Kepler University Linz"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Bei der Beurteilung der gesundheitlichen Eignung zum Lenken eines Kraftfahrzeuges ist die \u00f6ffentliche Sicherheit (Unfallpr\u00e4vention) das vorrangige Ziel. Der generelle Zugang zu Mobilit\u00e4t sollte jedoch nicht eingeschr\u00e4nkt werden, wenn kein besonderes Risiko f\u00fcr die \u00f6ffentliche Sicherheit besteht. F\u00fcr Menschen mit Diabetes mellitus sind im F\u00fchrerscheingesetz (FSG) und in der F\u00fchrerscheingesetz-Gesundheitsverordnung (FSG-GV) wichtige Aspekte zur Fahrsicherheit in Zusammenhang mit akuten und chronischen Komplikationen der Erkrankung geregelt. Zu den kritischen Komplikationen, die f\u00fcr die Verkehrssicherheit relevant sind, geh\u00f6ren schwere Hypoglyk\u00e4mie, ausgepr\u00e4gte Hyperglyk\u00e4mie und Hypoglyk\u00e4miewahrnehmungsst\u00f6rung sowie schwere Retinopathie und Neuropathie, des Weiteren fortgeschrittene Nierenerkrankung und bestimmte kardiovaskul\u00e4re Manifestationen. Bei Verdacht auf Pr\u00e4senz einer dieser Akutkomplikationen oder Folgesch\u00e4den ist eine genaue Evaluierung erforderlich. Dar\u00fcber hinaus ist die individuelle antihyperglyk\u00e4mische Medikation auf vorhandenes Potenzial f\u00fcr Hypoglyk\u00e4mien zu \u00fcberpr\u00fcfen. Sulfonylharnstoffe, Glinide und Insulin geh\u00f6ren in diese Gruppe und sind daher automatisch mit der Auflage einer 5\u2011j\u00e4hrigen Befristung des F\u00fchrerscheines assoziiert. Metformin, Dipeptidyl-Peptidase-4 Hemmer (DPP-4 Hemmer, Gliptine), Natrium-Glukose-Cotransporter-2 Hemmer (SGLT-2 Hemmer, Gliflozine), Glitazone und die zu injizierenden Glukagon like Peptide-1-Rezeptoragonisten (GLP-1-Rezeptoragonisten) sowie duale GLP-1- und Glucose dependent insulinotropic Peptide-Rezeptoragonisten (GLP-1\/GIP-Rezeptoragonisten) weisen kein Hypoglyk\u00e4miepotenzial auf und sind daher nicht mit einer Befristung verbunden. Die FSG-GV gibt Spielraum f\u00fcr Interpretation, sodass im Folgenden spezifische Themen zur Fahrsicherheit f\u00fcr Menschen mit Diabetes mellitus aus fach\u00e4rztlicher und verkehrsrelevanter Sicht aufgearbeitet wurden. Dieses Positionspapier dient zur Unterst\u00fctzung von Personen, die mit dieser herausfordernden Materie befasst sind.<\/jats:p>","DOI":"10.1007\/s00508-025-02655-y","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:13:52Z","timestamp":1779315232000},"page":"373-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes mellitus und Stra\u00dfenverkehr\u00a0\u2013 ein Positionspapier der \u00d6sterreichischen Diabetesgesellschaft (Update 2026)","Diabetes mellitus and road traffic\u2014A\u00a0position paper of the Austrian Diabetes Association (Update 2026)"],"prefix":"10.1007","volume":"138","author":[{"given":"Heidemarie","family":"Abrahamian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Kaltenegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Lahnsteiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schelkshorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Br\u00e4uer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Stechemesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Clodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2655_CR1","unstructured":"Englund L, O\u2019Neill DJ, Pisarek W, Ryan M, Wagner T. CIECA report medical fitness to drive. 2020. https:\/\/www.cieca.eu\/node\/959. Zugegriffen: 20. Juli 2022."},{"key":"2655_CR2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/euhj.1998.1120","volume":"19","author":"MC Petch","year":"1998","unstructured":"Petch\u00a0MC. Driving and heart disease. Eur Heart\u00a0J. 1998;19:1165\u201377.","journal-title":"Eur Heart J"},{"key":"2655_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0001-4575(96)00062-0","volume":"28","author":"H Sjogren","year":"1996","unstructured":"Sjogren\u00a0H, Eriksson\u00a0A, Ostrom\u00a0M. Role of disease in initiating the crashes of fatally injured drivers. Accid Anal Prev. 1996;28:307\u201314.","journal-title":"Accid Anal Prev"},{"key":"2655_CR4","unstructured":"Lindsay VLA, Baldock MRJ. Medical conditions as a\u00a0contributing factor in crash causation. Centre for Automotive Safety Research, University of Adelaide, South Australia, Australia. 2008. http:\/\/casr.adelaide.edu.au\/rsr\/RSR2008\/LindsayV.pdf. Zugegriffen: 20. Juli 2022."},{"key":"2655_CR5","unstructured":"Carson J, Jost G, Adminait\u00e9-Fodor D. Are medical fitness to drive procedures fit for purpose? PIN flash report 40. 2021. https:\/\/etsc.eu\/wp-content\/uploads\/PIN-Flash-40_Final.pdf. Zugegriffen: 20. Juli 2022."},{"issue":"1","key":"2655_CR6","first-page":"S114","volume":"127","author":"O Ebert","year":"2019","unstructured":"Ebert\u00a0O, Bohn\u00a0B, Bertram\u00a0B, Buchberger\u00a0B, Finck\u00a0H, Ho\u00df\u00a0J, et\u00a0al. Diabetes and road traffic. Exp Clin Endocrinol Diabetes. 2019;127(1):S114\u2013S23.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2655_CR7","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.2337\/diacare.27.10.2335","volume":"27","author":"AJ Sommerfield","year":"2004","unstructured":"Sommerfield\u00a0AJ, Deary\u00a0IJ, Frier\u00a0BM. Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care. 2004;27:2335\u201340.","journal-title":"Diabetes Care"},{"key":"2655_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/dom.12071","volume":"15","author":"B Inkster","year":"2013","unstructured":"Inkster\u00a0B, Frier\u00a0BM. Diabetes and driving. Diabetes Obes Metab. 2013;15:775\u201383.","journal-title":"Diabetes Obes Metab"},{"key":"2655_CR9","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2337\/dc08-1510","volume":"32","author":"DJ Cox","year":"2009","unstructured":"Cox\u00a0DJ, Ford\u00a0D, Gonder-Frederick\u00a0L, Clarke\u00a0W, Mazze\u00a0R, Weinger\u00a0K, et\u00a0al. Driving mishaps among individuals with type 1 diabetes: a\u00a0prospective study. Diabetes Care. 2009;32:2177\u201380.","journal-title":"Diabetes Care"},{"key":"2655_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/dom.12031","volume":"15","author":"JE Signorovitch","year":"2013","unstructured":"Signorovitch\u00a0JE, Macaulay\u00a0D, Diener\u00a0M, Yan\u00a0Y, Wu\u00a0EQ, Gruenberger\u00a0JB, et\u00a0al. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab. 2013;15:335\u201341.","journal-title":"Diabetes Obes Metab"},{"issue":"37","key":"2655_CR11","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc14-S097","volume":"1","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Diabetes and driving. Diabetes Care. 2014;1(37):S97\u2013S103.","journal-title":"Diabetes Care"},{"key":"2655_CR12","volume-title":"Plymouth Meeting","author":"ECRI","year":"2011","unstructured":"ECRI. Diabetes and commercial motor vehicle safety (Federal Motor Carrier Safety Administration). June 2011 update. In: Plymouth Meeting. Pennsylvania: ECRI; 2011."},{"key":"2655_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11920-006-0045-8","volume":"8","author":"L Jerome","year":"2006","unstructured":"Jerome\u00a0L, Habinski\u00a0L, Segal\u00a0A. Attention-deficit\/hyperactivity disorder (ADHD) and driving risk: a\u00a0review of the literature and a\u00a0methodological critique. Curr Psychiatry Rep. 2006;8:416\u201326.","journal-title":"Curr Psychiatry Rep"},{"key":"2655_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.5664\/jcsm.27662","volume":"5","author":"S Tregear","year":"2009","unstructured":"Tregear\u00a0S, Reston\u00a0J, Schoelles\u00a0K, Phillips\u00a0B. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and metaanalysis. J\u00a0Clin Sleep Med. 2009;5:573\u201381.","journal-title":"J Clin Sleep Med"},{"key":"2655_CR15","unstructured":"Diabetes and driving in Europe. A report of the Second European Group Working on Diabetes and Driving, an advisory board to the Driving License Committee of the European Union. 2005. http:\/\/ec.europa.eu\/transport\/road_safety\/pdf\/behavior\/diabetes_and_driving_in_europe_final_1_en.pdf. Zugegriffen: 18. Nov. 2022."},{"key":"2655_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.endonu.2015.11.003","volume":"63","author":"I Conget","year":"2016","unstructured":"Conget\u00a0I, Avila\u00a0D, Gimenez\u00a0M, Quiros\u00a0C, Salaverria\u00a0V, Duenas\u00a0B. Impaired awareness of hypoglycaemia in subjects with type 1 diabetes. Results of an online survey in a\u00a0diabetes web site. Endocrinol Nutr. 2016;63:121\u20135.","journal-title":"Endocrinol Nutr"},{"key":"2655_CR17","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0506","author":"AJ Flatt","year":"2023","unstructured":"Flatt\u00a0AJ, Peleckis\u00a0AJ, Dalton-Bakes\u00a0C, et\u00a0al. Automated Insulin delivery for hypoglycemia avoidance and glucose counterregulation in long-standing type 1 diabetes with hypoglycemia unawareness. Diabetes Technol Ther. 2023; https:\/\/doi.org\/10.1089\/dia.2022.0506.","journal-title":"Diabetes Technol Ther"},{"key":"2655_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00125-022-05749-8","volume":"65","author":"CEM Verhulst","year":"2022","unstructured":"Verhulst\u00a0CEM, Fabricius\u00a0TW, Teerenstra\u00a0S, Kristensen\u00a0PL, Cees\u00a0JT, McCrimmon\u00a0RJ, et\u00a0al. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a\u00a0systematic review. Diabetologia. 2022;65:1601\u201312.","journal-title":"Diabetologia"},{"key":"2655_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2337\/diab.32.2.134","volume":"32","author":"G Bolli","year":"1983","unstructured":"Bolli\u00a0G, de Feo\u00a0P, Compagnucci\u00a0P, Cartechini\u00a0MG, Angeletti\u00a0G, Santeusanio\u00a0F, et\u00a0al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin anti-bodies and impaired glucagon and epinephrine secretion. Diabetes. 1983;32:134\u201341.","journal-title":"Diabetes"},{"issue":"3","key":"2655_CR20","first-page":"74","volume":"36","author":"AJ Graveling","year":"2010","unstructured":"Graveling\u00a0AJ, Frier\u00a0BM. Impaired awareness of hypoglycaemia: a\u00a0review. Diabetes Metab. 2010;36(3):74.","journal-title":"Diabetes Metab"},{"key":"2655_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00125-008-1205-7","volume":"52","author":"PE Cryer","year":"2009","unstructured":"Cryer\u00a0PE. Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia. 2009;52:35\u20137.","journal-title":"Diabetologia"},{"key":"2655_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2337\/diacare.23.2.163","volume":"23","author":"DJ Cox","year":"2000","unstructured":"Cox\u00a0DJ, Gonder-Frederick\u00a0LA, Kovatchev\u00a0BP, Julian\u00a0DM, Clarke\u00a0WL. Progressive hypoglycemia\u2019s impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care. 2000;23:163\u201370.","journal-title":"Diabetes Care"},{"key":"2655_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/diacare.18.4.517","volume":"18","author":"WL Clarke","year":"1995","unstructured":"Clarke\u00a0WL, Cox\u00a0DJ, Gonder-Frederick\u00a0L, Julian\u00a0D, Schlundt\u00a0D, Polonsky\u00a0W. Reduced awareness of hypoglycemia in adults with IDDM. Diabetes Care. 1995;18:517\u201322.","journal-title":"Diabetes Care"},{"key":"2655_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","volume":"4","author":"CAJ van Beers","year":"2016","unstructured":"van Beers\u00a0CAJ, DeVries\u00a0JH, Kleijer\u00a0SJ, Smits\u00a0MM, Geelhoed-Duijvestijn\u00a0PH, Kramer\u00a0MHH, et\u00a0al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a\u00a0randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016;4:893\u2013902.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2655_CR25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2337\/dc20-2250","volume":"44","author":"OJ Collyns","year":"2021","unstructured":"Collyns\u00a0OJ, Meier\u00a0RA, Betts\u00a0ZL, Chan\u00a0DSH, Frampton\u00a0C, Frewen\u00a0CM, et\u00a0al. Improved glycemic outcomes with medtronic MiniMed advanced hybrid closed-loop delivery: results from a\u00a0randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care. 2021;44(4):969\u201375. https:\/\/doi.org\/10.2337\/dc20-2250.","journal-title":"Diabetes Care"},{"issue":"5","key":"2655_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/dia.2020.0572","volume":"23","author":"E Isganaitis","year":"2021","unstructured":"Isganaitis\u00a0E, Raghinaru\u00a0D, Ambler-Osborn\u00a0L, Pinsker\u00a0JE, Buckingham\u00a0BA, Wadwa\u00a0RP, et\u00a0al. Closed-loop insulin therapy improves glycemic control in adolescents and young adults: outcomes from the International Diabetes Closed-loop Trial. Diabetes Technol Ther. 2021;23(5):342\u20139.","journal-title":"Diabetes Technol Ther"},{"key":"2655_CR27","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.2337\/dc15-0102","volume":"38","author":"E Yeoh","year":"2015","unstructured":"Yeoh\u00a0E, Choudhary\u00a0P, Nwokolo\u00a0M, Ayis\u00a0S, Amiel\u00a0SA. Interventions that restore awareness of hypoglycemia in adults with type 1 diabetes: A\u00a0systematic review and meta-analysis. Diabetes Care. 2015;38:1592\u2013609.","journal-title":"Diabetes Care"},{"key":"2655_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2337\/diacare.28.1.71","volume":"28","author":"DJ Cox","year":"2005","unstructured":"Cox\u00a0DJ, Kovatchev\u00a0BP, Gonder-Frederick\u00a0LA, Summers\u00a0KH, McCall\u00a0A, Grimm\u00a0KJ, et\u00a0al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care. 2005;28:71\u20137.","journal-title":"Diabetes Care"},{"key":"2655_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000067947","volume":"49","author":"W Hewer","year":"2003","unstructured":"Hewer\u00a0W, Mussell\u00a0M, Rist\u00a0F, Kulzer\u00a0B, Bergis\u00a0K. Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes. Gerontology. 2003;49:86\u201392.","journal-title":"Gerontology"},{"key":"2655_CR30","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2337\/dc08-1722","volume":"32","author":"LA Gonder-Frederick","year":"2009","unstructured":"Gonder-Frederick\u00a0LA, Zrebiec\u00a0JF, Bauchowitz\u00a0AU, Ritterband\u00a0LM, Magee\u00a0JC, Cox\u00a0DJ, et\u00a0al. Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a\u00a0field study. Diabetes Care. 2009;32:1001\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"2655_CR31","first-page":"6","volume":"7","author":"H Abrahamian","year":"2014","unstructured":"Abrahamian\u00a0H. Diabetes und F\u00fchrerschein. J\u00a0Klin Endokrinol Stoffw. 2014;7(1):6\u201310.","journal-title":"J Klin Endokrinol Stoffw"},{"key":"2655_CR32","unstructured":"\u201eLeitlinien f\u00fcr die gesundheitliche Eignung von Kraftfahrzeuglenkern\u201c, (Ein Handbuch f\u00fcr Amts- und Fach\u00e4rzte und die Verwaltung) im Auftrag des BM f\u00fcr Verkehr, Innovation und Technologie. 2019. https:\/\/www.bmk.gv.at\/dam\/jcr:a89edf17-d076-4855-aa0a-6b22b3542a26\/gesundheit_leitlinien.pdf. Zugegriffen: 18. Nov. 2022."},{"issue":"3","key":"2655_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1053\/j.jfas.2017.01.043","volume":"56","author":"KE Spiess","year":"2017","unstructured":"Spiess\u00a0KE, Sansosti\u00a0LE, Meyr\u00a0AJ. Diabetic driving studies-Part 2: a\u00a0comparison of brake response time between drivers with diabetes with and without lower extremity sensorimotor neuropathy. J\u00a0Foot Ankle Surg. 2017;56(3):573\u20136.","journal-title":"J Foot Ankle Surg"},{"issue":"3","key":"2655_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.jfas.2017.01.044","volume":"56","author":"LE Sansosti","year":"2017","unstructured":"Sansosti\u00a0LE, Spiess\u00a0KE, Meyr\u00a0AJ. Diabetic driving studies-Part 3: a\u00a0comparison of mean brake response time between Neuropathic diabetic drivers with and without foot pathology. J\u00a0Foot Ankle Surg. 2017;56(3):577\u201380.","journal-title":"J Foot Ankle Surg"},{"key":"2655_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4093\/dmj.2016.40.3.202","volume":"40","author":"SA Cha","year":"2016","unstructured":"Cha\u00a0SA, Yun\u00a0JS, Lim\u00a0TS, Hwang\u00a0S, Yim\u00a0EJ, Song\u00a0KH, et\u00a0al. Severe hypoglycemia and cardio-vascular or all-cause mortality in patients with type 2 diabetes. Diabetes Metab\u00a0J. 2016;40:202\u201310.","journal-title":"Diabetes Metab J"},{"issue":"131","key":"2655_CR36","first-page":"S1","volume":"1","author":"-","year":"2019","unstructured":"-. Leitlinien der \u00d6sterreichischen Diabetesgesellschaft. Wien Klin Wochenschr. 2019;1(131):S1\u2013S246.","journal-title":"Wien Klin Wochenschr"},{"issue":"7","key":"2655_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrendo.2017.39","volume":"13","author":"C Mathieu","year":"2017","unstructured":"Mathieu\u00a0C, Gillard\u00a0P, Benhalima\u00a0K. Insulin analogues in type 1 diabetes mellitus: getting better all the time. Nat Rev Endocrinol. 2017;13(7):385\u201399. https:\/\/doi.org\/10.1038\/nrendo.2017.39.","journal-title":"Nat Rev Endocrinol"},{"key":"2655_CR38","doi-asserted-by":"publisher","first-page":"105334","DOI":"10.1016\/j.aap.2019.105334","volume":"134","author":"S Ma","year":"2020","unstructured":"Ma\u00a0S, Zhang\u00a0J, Zeng\u00a0X, Wu\u00a0C, Zhao\u00a0G, Lv\u00a0C, et\u00a0al. Type 2 diabetes can undermine driving performance of middle-aged male drivers through its deterioration of perceptual and cognitive functions. Accid Anal Prev. 2020;134:105334. https:\/\/doi.org\/10.1016\/j.aap.2019.105334.","journal-title":"Accid Anal Prev"},{"key":"2655_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40621-020-00265-y","volume":"7","author":"LL Hill","year":"2020","unstructured":"Hill\u00a0LL, Andrews\u00a0H, Li\u00a0G, DiGuiseppi\u00a0CG, Betz\u00a0ME, Strogatz\u00a0D, et\u00a0al. Medication use and driving patterns in older drivers:preliminary findings from the LongROAD study. Inj Epidemiol. 2020;7:38. https:\/\/doi.org\/10.1186\/s40621-020-00265-y.","journal-title":"Inj Epidemiol"},{"key":"2655_CR40","unstructured":"Driver & Vehicle Licensing Agency. A\u00a0guide to insulin treated diabetes and driving (INF294). 2013. http:\/\/www.dvla.gov.uk. Zugegriffen: 18. Nov. 2022."},{"key":"2655_CR41","unstructured":"Deutsche Diabetesgesellschaft (DDG). Diabetes und Stra\u00dfenverkehr. 2017. https:\/\/www.deutsche-diabetes-gesellschaft.gesellschaft.de\/leitlinien\/evidenzbasierte-leitlinien.html. Zugegriffen: 18. Nov. 2022."},{"key":"2655_CR42","unstructured":"Deutsche Diabetes Gesellschaft (DDG). \u201ePatientenleitlinie Diabetes und Stra\u00dfenverkehr\u201c 1. Auflage, Version 1 vom 06.11.2019 https:\/\/www.deutsche-diabetes-gesellschaft.de\/leitlinien\/patienten-leitlinien.html. Zugegriffen: 18. Nov. 2022."},{"key":"2655_CR43","volume-title":"Arbeitsgruppe der SGED, SGD und der SGRM: Richtlinien bez\u00fcglich Fahreignung und Fahrf\u00e4higkeit bei Diabetes mellitus","author":"R Lehmann","year":"2017","unstructured":"Lehmann\u00a0R, Czock\u00a0A, Egli\u00a0M, Fischer-Taeschler\u00a0D, Iselin\u00a0HU, Pavlicek\u00a0V, et\u00a0al. Arbeitsgruppe der SGED, SGD und der SGRM: Richtlinien bez\u00fcglich Fahreignung und Fahrf\u00e4higkeit bei Diabetes mellitus. 2017."}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-025-02655-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:13:56Z","timestamp":1779315236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-025-02655-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":43,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2655"],"URL":"https:\/\/doi.org\/10.1007\/s00508-025-02655-y","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.\u00a0Abrahamian, G.\u00a0K\u00f6hler, B.\u00a0Salamon, A.\u00a0Kaltenegger, A.\u00a0Lahnsteiner, C.\u00a0Schelkshorn, A.\u00a0Br\u00e4uer, L.\u00a0Stechemesser und M.\u00a0Clodi geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}